US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
CV

CVStockCapsoVision, Inc.

Nasdaq Capital Market · Healthcare · US

$6.76 last close 2026-10-12
Open in terminalCompare
Alert

Verdicts genuinely change. Free email alert the moment CV's does — no target price to set, unlike "Alert" above.

Sharia status
NOT YET SCREENED
Not screened yet — no methodology has been established for this symbol
HTR non-permissible income 1.98%

Methodology breakdown computing — it will appear here on its own.

🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No active setup right now. The technical picture doesn't show a clear edge — check back when the trend or momentum shifts.

Trade plan

Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.

MOM · SCALP
Entry
$6.72
Stop
$6.65
Target
$6.86
Risk : Reward 2.0R

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure3 of 5 timeframes bullish · 87.0% aligned
VWAPPrice holding above VWAP ($6.61)
VolumeRelative volume 1.3× the 20-day average
Momentum10-day rate of change -3.8%
Market & analysts
Price target
$9.50
+40.5% · 2 analysts
Institutional own.
9.7%
of shares
Momentum (10d)
-3.8%
rate of change
SMC grade
C · 55
87.0% aligned
1.95% *
Purification ratio (secondary provider, uncertain)
1.98%
Non-permissible income — HTR, from filings (2025-12-31)
C · 55
SMC grade — 87.0% timeframe alignment
-3.8%
Rate of change (10d)
$9.50
Price target (+40.5%) · 2 analysts
9.7%
Institutional ownership

🕌 In-house Compliance Research

Computing the full ratio and business-activity breakdown for CV — this runs off the critical path so the page paints first. It will appear here on its own.

14.4211.969.517.054.592025-10-132026-04-142026-10-12

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
6.31
S2
6.42
S1
6.51
PIVOT
6.62
R1
6.70
R2
6.81
R3
6.90

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
5.36 – 7.94
±19.47% from 6.65, made 2026-09-25 · resolves 2026-10-02
STRONG BUY
from 19 indicators
61.9% of our last 5789 forecasts landed inside their stated range, and 49.9% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG BUY
19 indicators
OscillatorsSTRONG SELL
1 buy · 1 neutral · 5 sell
Moving averagesSTRONG BUY
12 buy · 0 neutral · 0 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)56.60NEUTRAL
Stochastic %K (14)80.00SELL
CCI (20)103.91SELL
Williams %R (14)-20.00SELL
MACD (12,26,9)0.03BUY
ROC (10)-2.31SELL
Momentum (10)-0.16SELL
EMA (10)6.55BUY
SMA (10)6.52BUY
EMA (20)6.48BUY
SMA (20)6.45BUY
EMA (30)6.44BUY
SMA (30)6.36BUY
EMA (50)6.44BUY
SMA (50)6.39BUY
EMA (100)6.49BUY
SMA (100)6.58BUY
EMA (200)6.52BUY
SMA (200)6.51BUY

About CapsoVision, Inc.

Healthcare · Medical Devices

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

capsovision.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Latest Signal — 2026-09-14

MOM
Type · SCALP
6.72
Entry
6.65
Stop
6.86
Target
LOSS
Outcome

Stop 6.65 Now 6.76 Target 6.86

Grade verdict

Average — needs more confirmation before sizing up

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BULLISH 64
⏰ 4H BULLISH 28
🕐 1H BULLISH 98
⏱ 15-Min BEARISH 130
⏲ 5-Min BEARISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-3.8%
Rate of change (10d)
1.3×
Volume vs its 20-day average
0.07
MACD (no fresh cross)
$6.78
Volume POC (today)
$6.74 – $6.80
Value area

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-10-06 · Asset managers net 906615 (+2612)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.